Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06359678
Other study ID # NL85844.015.23
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date January 1, 2024
Est. completion date January 1, 2025

Study information

Verified date April 2024
Source Amsterdam UMC, location VUmc
Contact Marco Gotte
Phone 020-44440123
Email mjw.gotte@amsterdamumc.nl
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The introduction of real-time MRI-guided cardiac ablation therapy, a significant advancement in interventional medicine, necessitates precise catheter tracking for accurate navigation within the complex cardiac anatomy. The introduction of the NorthStar software as an active tracking system holds promise for improving the precision and efficiency of catheter manipulation during these procedures. However, a rigorous evaluation of its accuracy and reliability in a clinical setting is crucial to validate its viability. The objective of this study is to evaluate the accuracy of catheter localization using the NorthStar software during real-time MRI-guided cardiac ablation therapy.


Recruitment information / eligibility

Status Recruiting
Enrollment 20
Est. completion date January 1, 2025
Est. primary completion date January 1, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients undergoing a real-time MRI-guided flutter ablation procedure at the Amsterdam UMC. Exclusion Criteria: - Lack of legal capacity. - Insufficient proficiency in the Dutch language.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
NorthStar
Throughout the real-time MRI-guided ablation procedure, the operator will assess the precision of the NorthStar 3D navigation software. Before commencing the actual ablation, the operator will confirm the alignment of the 3D anatomical shell, generated in NorthStar through specific electrical signals. Post the ablation procedure, a secondary alignment verification will be conducted to detect any potential drift or shift.

Locations

Country Name City State
Netherlands Amsterdam UMC Amsterdam

Sponsors (1)

Lead Sponsor Collaborator
Amsterdam UMC, location VUmc

Country where clinical trial is conducted

Netherlands, 

Outcome

Type Measure Description Time frame Safety issue
Primary Accuracy of Catheter Localization The primary objective of this study is to evaluate the accuracy of catheter localization using the NorthStar software during realtime MRI-guided cardiac ablation therapy. At the start of the procedure, the catheters will be manoeuvred to the predefined areas within the right side of the heart based on the specific electrical signals in that area. These locations will be virtually marked within the NorthStar software. The extent to which these markers maintain their spatial coordinates after the ablation procedure, evaluated by obtained electrical signals, will serve as a quantitative measure of the system's accuracy. during procedure
Secondary Influences of breathing pattern To investigate the influence of breathing pattern on the accuracy of catheter localization. The breathing pattern during the procedure will be monitored and any changes will be related to the accuracy of catheter localization during procedure
Secondary Influences of procedure duration To investigate the influence of procedure duration on the accuracy of catheter localization. during procedure
Secondary Influences of complications during ablation To investigate the influence of complications during ablation on the accuracy of catheter localization. Complications during the procedure will be registered and categorized. during procedure
Secondary Influences of patient characteristics To investigate the influence of patient characteristics on the accuracy of catheter localization. Standard patient characteristics will be noted such as BMI, cardiac output and heartrate to investigate if these characteristics will influence the catheter localization. during procedure
See also
  Status Clinical Trial Phase
Completed NCT03250871 - Hypnosis in Interventional Electrophysiology N/A